Renaissance Capital logo

STVN News

Renaissance Capital’s July IPO Market Update

HOOD

55 IPOs raised $15.5 billion in the most active July since 1999 and the biggest for proceeds ever. The month’s IPOs were joined by 26 SPACs. Healthcare was the most active sector with 25 IPOs, mostly biotechs, as well as medical device makers and health service providers. Robinhood Markets produced the largest deal, raising $2.1 billion. The month’s IPOs averaged a 9%...read more

US IPO Weekly Recap: The summer IPO market heats up in a 13 IPO week

STVN

After a slow start to the month, the IPO market revved back to life with 13 IPOs coming to market this past week. SPAC activity picked up, with seven blank check IPOs raising $940 million. New filers continued to flood the IPO pipeline, with fourteen IPOs and nine SPACs submitting initial filings.   Italian drug container supplier Stevanato Group (STVN)...read more

Italian drug vial supplier Stevanato Group prices downsized US IPO at $21 low end

STVN

Stevanato Group, an Italian supplier of glass vials, syringes, and other pharmaceutical containers, raised $672 million by offering 32 million shares (70% primary) at $21, the low end of the range. It previously planned to sell 40 million shares (70% primary) at a range of $21 to $24. At the $21 offer price, Stevanato commands a market value of about $6.3 billion.  ...read more

US IPO Week Ahead: Real estate, post-pandemic plays and more in a 15 IPO week

STVN

Updated Monday, 7/12. After a slow holiday week, 15 IPOs are scheduled to raise nearly $4 billion in the week ahead. A handful of SPACs should also price. Italian drug container supplier Stevanato Group (STVN) plans to raise $900 million at a $6.8 billion market cap. Controlled by its founding family, the profitable company supplies glass vials,...read more